New combo shows promise for tough bile duct cancer
Disease control
Completed
This study tested a combination of two drugs, pembrolizumab and lenvatinib, in 27 people with advanced bile duct cancer that had stopped responding to standard treatments. The goal was to see if the combination could shrink tumors and control the disease. This is not a cure, but …
Phase: PHASE2 • Sponsor: Shanghai Jiahui International Hospital • Aim: Disease control
Last updated May 13, 2026 15:58 UTC